| Filed On | Filing |
|---|---|
| 13 Nov 2026 | 144 |
| 12 Nov 2026 |
Form 4: Mara Joseph Anthony Jr, Chief Financial Officer
Received 25,000 shares by exercise or conversion ($1.09M) · Sold 25,000 shares ($1.46M) · Acquired 25,000 Stock Option (Right to Buy) (Option Exercise/Conversion) · 3 more |
| 12 Nov 2026 |
Form 4: Mclaughlin Kevin F, Director
Received 7,000 shares by exercise or conversion ($91.4K) · Sold 7,000 shares ($413K) · Acquired 7,000 Stock Option (Right to Buy) (Option Exercise/Conversion) |
| 12 Nov 2026 |
Form 4: Zerbe Robert L Md, Director
Received 2,000 shares by exercise or conversion ($26.1K) · Sold 2,000 shares ($116K) · Acquired 2,000 Stock Option (Right to Buy) (Option Exercise/Conversion) |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 09 Nov 2026 |
Form 4: Mara Joseph Anthony Jr, Chief Financial Officer
Received 21,359 shares by exercise or conversion ($692K) · Sold 21,359 shares ($1.14M) · Acquired 21,359 Stock Option (Right to Buy) (Option Exercise/Conversion) · 3 more |
| 06 Nov 2026 | 144/A |
| 06 Nov 2026 | 144 |
| 06 Nov 2026 |
Form 4: Siegal Jonathan, Principal Accounting Officer
Received 1,500 shares by exercise or conversion ($52.4K) · Sold 1,500 shares ($79.4K) · Acquired 1,500 Stock Option (Right to Buy) (Option Exercise/Conversion) |
| 06 Nov 2026 |
Form 4: Flynn Sean C., Chief Legal Officer
Received 15,000 shares by exercise or conversion ($244K) · Sold 15,000 shares ($779K) · Acquired 15,000 Stock Option (Right to Buy) (Option Exercise/Conversion) |
| 06 Nov 2026 |
Form 4: Zerbe Robert L Md, Director
Received 2,500 shares by exercise or conversion ($32.6K) · Sold 2,500 shares ($114K) · Acquired 2,500 Stock Option (Right to Buy) (Option Exercise/Conversion) · 3 more |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 144 |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, Mass., November 5, 2026 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for t... |
Loading...